Cycloheximide Protects HepG2 Cells from Serum Withdrawal-Induced Apoptosis by Decreasing p53 and Phosphorylated p53 Levels

Cycloheximide (CHX), an inhibitor of protein synthesis, has been reported to prevent cell death in a wide variety of cell types and produced by different apoptotic stimuli. However, the mechanisms by which CHX protects cells from apoptosis are still unclear. In this study, we investigated whether p53 plays a role in the protection by CHX against serum withdrawal-induced apoptosis. Deprivation of serum from the culture medium causes apoptosis in HepG2 cells, and CHX dramatically protects cells from death. p53, p21, and Bax protein levels were elevated, and cell cycle arrest was produced after serum withdrawal. CHX abolished this elevation of p53, p21, and Bax as well as the cell cycle arrest induced by serum deprivation. The p53 inhibitor pifithrin-α protects HepG2 cells against apoptosis induced by serum withdrawal. HepG2 cells expressing a dominant negative form of mutant p53 and Hep3B cells lacking p53 were resistant to serum withdrawal-induced apoptosis. Lowering of p53 by small interfering RNA protects HepG2 cells from serum withdrawal-induced apoptosis. p53 phosphorylation was induced by serum withdrawal and other chemotherapeutic reagents such as actinomycin D, doxorubicin, and etoposide. CHX decreases the levels of phosphorylated p53 (pp53) even in the presence of a proteasome inhibitor, which maintains the total p53 levels, whereas it does not affect the dephosphorylation of pp53. These results suggest the possibility that kinases that phosphorylate p53 might be affected by CHX administration. In summary, CHX protects HepG2 cells from serum withdrawal-induced apoptosis through inhibiting the synthesis of p53 and the phosphorylation of p53.

[1]  C. Schamberger,et al.  Caspase-9 plays a marginal role in serum starvation-induced apoptosis. , 2005, Experimental cell research.

[2]  M. Ljungman,et al.  Pifithrin-α Inhibits p53 Signaling after Interaction of the Tumor Suppressor Protein with hsp90 and Its Nuclear Translocation* , 2004, Journal of Biological Chemistry.

[3]  R. Hamdy,et al.  Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice , 2004 .

[4]  G Gstraunthaler,et al.  The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  R. Hamdy,et al.  Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. , 2004, American journal of physiology. Heart and circulatory physiology.

[6]  M. Mattson,et al.  Anti-apoptotic actions of cycloheximide: blockade of programmed cell death or induction of programmed cell life? , 2004, Apoptosis.

[7]  R. Collins,et al.  Cycloheximide and actinomycin D delay death and affect bcl‐2, bax, and Ice gene expression in astrocytes under in vitro ischemia , 2003, Journal of neuroscience research.

[8]  D. Crossman,et al.  A Role for Caspase-1 in Serum Withdrawal-Induced Apoptosis of Endothelial Cells , 2003, Laboratory Investigation.

[9]  Youngki Lee,et al.  Insulin can block apoptosis by decreasing oxidative stress via phosphatidylinositol 3-kinase- and extracellular signal-regulated protein kinase-dependent signaling pathways in HepG2 cells. , 2003, European journal of endocrinology.

[10]  K. Kinzler,et al.  PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.

[11]  Yusuke Nakamura,et al.  p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.

[12]  S. Fulda,et al.  Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. , 2000, Cancer research.

[13]  T. Taniguchi,et al.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.

[14]  J. Melendez,et al.  Overexpression of Catalase in Cytosolic or Mitochondrial Compartment Protects HepG2 Cells against Oxidative Injury* , 1999, The Journal of Biological Chemistry.

[15]  M V Chernov,et al.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.

[16]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[17]  M. Benito,et al.  Cycloheximide prevents apoptosis, reactive oxygen species production, and glutathione depletion induced by transforming growth factor β in fetal rat hepatocytes in primary culture , 1997, Hepatology.

[18]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[19]  M. Manns,et al.  Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b. , 1997, Journal of hepatology.

[20]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[21]  K. Kinzler,et al.  14-3-3sigma is a p53-regulated inhibitor of G2/M progression. , 1997, Molecular cell.

[22]  H. Hatanaka,et al.  Survival factor-insensitive generation of reactive oxygen species induced by serum deprivation in neuronal cells , 1996, Brain Research.

[23]  E. May,et al.  Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. , 1995, Oncogene.

[24]  B. Hoffman,et al.  Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. , 1995, Oncogene.

[25]  K. Kinzler,et al.  Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. , 1995, Cancer research.

[26]  J. Roth,et al.  Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression , 1995, Molecular and cellular biology.

[27]  S. Lipton,et al.  Transcriptional or translational inhibition blocks low dose NMDA-mediated cell death , 1995, Neuroreport.

[28]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[29]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[30]  B. Sola,et al.  Cycloheximide, and actinomycin D block the toxic effect of glutamic acid on PC12cells , 1994, Neuroreport.

[31]  T. Murphy,et al.  Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  J C Mills,et al.  A system for characterizing cellular and molecular events in programmed neuronal cell death , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  M. Fritsche,et al.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.

[34]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[35]  Bert Vogelstein,et al.  p53 function and dysfunction , 1992, Cell.

[36]  P. Distefano,et al.  Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation , 1988, The Journal of cell biology.

[37]  A. Wyllie,et al.  Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis , 1984, The Journal of pathology.